Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
cardamine's Profile
Displaying 1-50 of 1756 result(s).
CYDY CytoDyn Inc
08/09/2025 2:51:48 PM
I was disagreeing with the phrase " (4)
CYDY CytoDyn Inc
08/09/2025 11:31:09 AM
Wow...is that your full capacity fo (5)
CYDY CytoDyn Inc
08/09/2025 10:46:47 AM
oy that sounds like a con...Mehmet (6)
CYDY CytoDyn Inc
08/07/2025 5:27:35 PM
side note: they can definitely lega (5)
CYDY CytoDyn Inc
07/31/2025 8:55:33 PM
(I did NOT mean an emoji! I meant t (4)
CYDY CytoDyn Inc
07/31/2025 7:52:12 PM
(fwiw: "While specific adverse even (3)
CYDY CytoDyn Inc
07/30/2025 1:30:00 AM
Thank you for writing all this out- (3)
CYDY CytoDyn Inc
07/30/2025 12:50:56 AM
Quick Question re right to try/comp (5)
CYDY CytoDyn Inc
07/29/2025 3:23:29 PM
still as of yesterday, only approx
CYDY CytoDyn Inc
07/25/2025 5:33:00 PM
Ah thank you--that helps.
CYDY CytoDyn Inc
07/25/2025 5:22:32 PM
(side question: what's the differen (2)
CYDY CytoDyn Inc
07/25/2025 5:05:42 PM
Amarex paid up in June, so that's g (4)
CYDY CytoDyn Inc
07/24/2025 9:13:27 PM
AH, ok -- "we" with no antecedent, (1)
CYDY CytoDyn Inc
07/24/2025 7:12:11 PM
YES to Sean - No More shareholders (19)
CYDY CytoDyn Inc
07/23/2025 3:07:08 PM
Wiki even makes a separate section (2)
CYDY CytoDyn Inc
07/23/2025 2:53:12 PM
yeah there's been the proverbial "b (1)
CYDY CytoDyn Inc
07/17/2025 7:15:06 PM
A company can *definitely* say they (3)
CYDY CytoDyn Inc
07/16/2025 10:18:30 AM
Or in the words of the great Denzel (3)
CYDY CytoDyn Inc
07/16/2025 12:26:38 AM
Looks like that 5-year sample deadl (3)
CYDY CytoDyn Inc
07/10/2025 11:24:00 PM
From April...I do NOT agree with ev (7)
CYDY CytoDyn Inc
07/08/2025 11:19:50 PM
thanks, brentie -- LL's the only CC (2)
CYDY CytoDyn Inc
07/07/2025 2:44:46 PM
poster display session in Hall B0
CYDY CytoDyn Inc
07/03/2025 3:52:25 PM
Will provide a good opp for compari (2)
CYDY CytoDyn Inc
07/01/2025 1:51:46 PM
Atezolizumab serious side effects: (9)
CYDY CytoDyn Inc
07/01/2025 1:09:14 PM
I wonder could they revise it...tha (2)
CYDY CytoDyn Inc
06/26/2025 2:15:23 PM
(sorry, was clicking the thumbs up (1)
CYDY CytoDyn Inc
06/26/2025 1:12:45 AM
"1st CRC trial dosed 5 patients. Ou (2)
CYDY CytoDyn Inc
06/25/2025 9:07:55 PM
EXACTLY -- we've been like the Stat (7)
CYDY CytoDyn Inc
06/25/2025 4:32:41 PM
I think they have to endorse it in (5)
CYDY CytoDyn Inc
06/24/2025 10:20:03 AM
Gilead's all over the news...some g
CYDY CytoDyn Inc
06/24/2025 12:02:57 AM
I think that's up to the co...
CYDY CytoDyn Inc
06/18/2025 11:51:22 PM
Should someone tell these advocates (4)
CYDY CytoDyn Inc
06/17/2025 12:30:34 PM
I wouldn't buy it/wouldn't have bou (1)
CYDY CytoDyn Inc
06/16/2025 9:24:34 PM
Please Dr. L -- shareholder update (9)
CYDY CytoDyn Inc
06/12/2025 9:29:08 PM
I wonder will Makary get to us in t (2)
CYDY CytoDyn Inc
06/11/2025 7:58:08 PM
And lapatinib can have serious hear (1)
CYDY CytoDyn Inc
06/11/2025 3:28:22 PM
To be fair (said in your best Lette (1)
CYDY CytoDyn Inc
06/09/2025 1:24:58 AM
I get the feeling it's *almost* tim (11)
CYDY CytoDyn Inc
06/02/2025 2:10:57 PM
Sure, but.......does he get it?
CYDY CytoDyn Inc
05/29/2025 1:33:17 AM
It's been a while since the last sh
CYDY CytoDyn Inc
05/28/2025 3:11:05 PM
Interesting - don't know, but they (1)
CYDY CytoDyn Inc
05/28/2025 1:43:04 PM
To some extent I agree with you, in (3)
CYDY CytoDyn Inc
05/28/2025 11:31:48 AM
quick googling -- blenrep possibly? (2)
CYDY CytoDyn Inc
05/28/2025 10:11:25 AM
These kinds of predictions are so p (1)
CYDY CytoDyn Inc
05/24/2025 1:05:33 AM
...and then not DOWN $6500 the next (1)
CYDY CytoDyn Inc
05/23/2025 3:27:02 PM
welp, bought from $3 - $6, watched (6)
CYDY CytoDyn Inc
05/23/2025 12:56:52 AM
Ohm, thank you so much! For me the (7)
CYDY CytoDyn Inc
05/22/2025 11:11:49 PM
Heard about a mab that was addressi (2)
CYDY CytoDyn Inc
05/21/2025 10:44:57 AM
Salutary info re supposedly fabulou
CYDY CytoDyn Inc
05/20/2025 3:49:15 PM
Would be a great character to write (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • PharmaTher Secures FDA Approval for KETARx™ Ketamine Therapy
  • Tevogen's Strategic Focus on AI and Growth Opportunities
  • Celebrating Healthcare Heroes: ImageFIRST's 5th Annual Contest
  • Record Highs Prompt New Insights on US Stock Valuation
  • Artelo Biosciences Advances ART27.13 with Patent Allowance
  • Cook & Boardman Group Expands with A.J. Labourdette Acquisition
  • Xiao-I Corporation Strengthens AI Partnership for Kitchen Leaders
  • Unleashing Confidence: TRESemmé's Vibrant New Campaign
  • Understanding Market Risks with Cushman & Wakefield and Compass
  • Mister Sparky Prepares Homeowners for Hurricane Season
  • Future of Digital Potentiometers: Insights and Growth Trends
  • Algebrik AI Partners with Open Lending for Enhanced Auto Loans
  • Investing in High-Dividend Tech & Telecom Stocks: An Overview
  • Harnessing Quantum AI for the Future of Technology
  • Damon Inc. Hits New Milestone in Next-Gen Performance Bikes
  • Innovations Driving Growth in 3D Printing Plastic Market
  • Jinx Unveils Fresh Refrigerated Dog Food Line for Pets
  • Orbia Netafim Launches Innovative Mega-PULSAR for Orchard Resilience
  • High-Speed Op Amps Market to Reach $7.38 Billion by 2032
  • Understanding the Rise of Foreign Reinsurance in Life Insurance
  • Unveiling the Impact of AI on Marketing Strategies and Engagement
  • Vizsla Copper Unveils New Transfer Agent for Shareholders
  • Projected Growth in the Polyamide Market by 2034
  • Qualia Life Sciences Welcomes Dan Pardi as New Chief Health Officer
  • Xiao-I Corporation Strengthens AI Solutions for Kitchen Appliances
  • Projected Growth of the Cancer Vaccines Market Through 2032
  • Kroger and C&S Wholesale Grocers Settle Legal Dispute Successfully
  • Discovering Your Calling: Insights from the Lindell Brothers
  • Artelo Biosciences Secures European Patent for ART27.13
  • Safal Partners Earns Prestigious ISO Certifications for Quality
  • Sonnet BioTherapeutics Expands Clinical Trial for Ovarian Cancer
  • Support for Teamsters Grows Amid Contract Negotiation Strikes
  • BioCardia Updates on Progress and Financial Performance
  • Karma Amaris: Revolutionizing Luxury with Hybrid Performance
  • Leadership Changes at TERREPOWER: Richard Longsdorf Takes Charge
  • Wrap Technologies Unveils Innovative Body-Worn Camera Solutions
  • Next Technology's New Dividend Policy Promises High Returns
  • Next Technology Holding Inc. Reports Remarkable H1 2025 Growth
  • Transforming Connectivity: Nokia and MX Fiber's Initiative
  • EuroDry Ltd. Releases Financial Results for Q2 and First Half of 2025
  • XOMA Royalty Successfully Completes Acquisition of Turnstone
  • Exciting Advancements Announced for VMware Explore 2025 Event
  • Tiziana Life Sciences Advances Intranasal Foralumab for MSA
  • LPL Financial Celebrates Success at Focus 2025 Conference
  • NeOnc Technologies Partners with Quazar for Major Investment
  • Windtree Therapeutics Showcases Istaroxime Breakthrough at HFSA
  • Cloudastructure's CEO Discusses Innovation on The Big Biz Show
  • Bullet Blockchain and Tangem Forge Partnership to Enhance Crypto Solutions
  • Telos Corporation Reports Strong Q2 2025 Financial Performance
  • EXL Enhances Global Reach with New Dublin Headquarters and AI Lab
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site